Amgen Inc: Stock Rating Summary
 Amgen Inc, a large-cap growth company in the health care sector, is expected to outperform the market over the next six months with very low risk. 10 is the best possible rating.
- Pro
- The price-to-earnings multiple is lower than average for all stocks in the StockScouter universe. Positive
- The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Very positive for a medium- to large-sized company like AMGN
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
- Con
- One or more analysts has modestly decreased quarterly earnings estimates for AMGN. Negative
Learn more about the StockScouter rating system.
|
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that growth stocks will be neutral, large-cap stocks will be neutral, and health care stocks will be neutral. More on market trends
advertisement
| Previous Ratings |
|---|
| 1 Month ago | 9 |
| 3 Months ago | 8 |
| 6 Months ago | 8 |
|
Page generated 11/26/2009 2:59 AM Eastern Time
Recent News
